Validation and psychometric properties of the Asthma Control Questionnaire among children

IF 11.4 1区 医学 Q1 ALLERGY Journal of Allergy and Clinical Immunology Pub Date : 2014-01-01 DOI:10.1016/j.jaci.2013.06.029
Jessica M. Nguyen MD , Janet T. Holbrook PhD, MPH , Christine Y. Wei MS , Lynn B. Gerald PhD , W. Gerald Teague MD , Robert A. Wise MD , American Lung Association Asthma Clinical Research Centers
{"title":"Validation and psychometric properties of the Asthma Control Questionnaire among children","authors":"Jessica M. Nguyen MD ,&nbsp;Janet T. Holbrook PhD, MPH ,&nbsp;Christine Y. Wei MS ,&nbsp;Lynn B. Gerald PhD ,&nbsp;W. Gerald Teague MD ,&nbsp;Robert A. Wise MD ,&nbsp;American Lung Association Asthma Clinical Research Centers","doi":"10.1016/j.jaci.2013.06.029","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The Asthma Control Questionnaire (ACQ) is a patient-centered tool for evaluating asthma control. It has been validated in adults, but not well-validated among children.</p></div><div><h3>Objective</h3><p>We evaluated the reliability, validity, and responsiveness to change of the ACQ for assessing asthma control in children ages 6 to 17 years. A threshold value for poor disease control and a minimally important difference were also determined.</p></div><div><h3>Methods</h3><p>Data from 305 asthmatic children enrolled in a clinical trial were examined. The ACQ was administered at 8 visits. We analyzed results for the combined age group and for the 6- to 11-year-old and 12- to 17-year-old age groups separately.</p></div><div><h3>Results</h3><p>Overall, the Cronbach α value (internal consistency) for the ACQ was 0.74 at baseline, and the intraclass correlation coefficient (test-retest reliability) for repeated questionnaires among stable patients was 0.53. The Pearson correlations between the ACQ and other asthma questionnaires were moderate to strong (−0.64 to −0.73). Mean ACQ scores were higher (worse) in patients whose peak flow decreased, who used more rescue medications, or who sought medical care for asthma than in patients who were stable (<em>P</em> &lt; .0001 for all measures). Changes in ACQ scores were significantly different among patients with deteriorating, improving, or stable asthma symptoms (<em>P</em> ≤ .01). The optimal threshold indicating poor asthma control was 1.25 or greater. The minimally important difference was established to be 0.40. Results for the separate age groups were similar.</p></div><div><h3>Conclusion</h3><p>The ACQ is a moderately reliable, valid, and responsive tool with adequate psychometric properties for assessing recent asthma control among children.</p></div>","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"133 1","pages":"Pages 91-97.e6"},"PeriodicalIF":11.4000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jaci.2013.06.029","citationCount":"49","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0091674913009974","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 49

Abstract

Background

The Asthma Control Questionnaire (ACQ) is a patient-centered tool for evaluating asthma control. It has been validated in adults, but not well-validated among children.

Objective

We evaluated the reliability, validity, and responsiveness to change of the ACQ for assessing asthma control in children ages 6 to 17 years. A threshold value for poor disease control and a minimally important difference were also determined.

Methods

Data from 305 asthmatic children enrolled in a clinical trial were examined. The ACQ was administered at 8 visits. We analyzed results for the combined age group and for the 6- to 11-year-old and 12- to 17-year-old age groups separately.

Results

Overall, the Cronbach α value (internal consistency) for the ACQ was 0.74 at baseline, and the intraclass correlation coefficient (test-retest reliability) for repeated questionnaires among stable patients was 0.53. The Pearson correlations between the ACQ and other asthma questionnaires were moderate to strong (−0.64 to −0.73). Mean ACQ scores were higher (worse) in patients whose peak flow decreased, who used more rescue medications, or who sought medical care for asthma than in patients who were stable (P < .0001 for all measures). Changes in ACQ scores were significantly different among patients with deteriorating, improving, or stable asthma symptoms (P ≤ .01). The optimal threshold indicating poor asthma control was 1.25 or greater. The minimally important difference was established to be 0.40. Results for the separate age groups were similar.

Conclusion

The ACQ is a moderately reliable, valid, and responsive tool with adequate psychometric properties for assessing recent asthma control among children.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿童哮喘控制问卷的有效性及心理测量学特征
背景哮喘控制问卷(ACQ)是一种以患者为中心的评估哮喘控制的工具。它在成人中得到了证实,但在儿童中却没有得到很好的证实。目的评价6 ~ 17岁儿童哮喘控制评价指标ACQ变化的信度、效度和响应性。还确定了疾病控制不良的阈值和最小重要差异。方法对305例哮喘患儿的临床资料进行分析。ACQ在8次访问中进行。我们分别分析了综合年龄组、6- 11岁年龄组和12- 17岁年龄组的结果。结果总体而言,基线时ACQ的Cronbach α值(内部一致性)为0.74,稳定患者重复问卷的类内相关系数(重测信度)为0.53。ACQ与其他哮喘问卷之间的Pearson相关性为中至强(- 0.64至- 0.73)。与病情稳定的患者相比,血流量峰值下降、使用更多抢救药物或因哮喘就医的患者的平均ACQ评分更高(更差)(P <所有测量值为0.0001)。哮喘症状恶化、改善和稳定患者的ACQ评分变化差异有统计学意义(P≤0.01)。哮喘控制不良的最佳阈值为1.25或更高。最小重要差异确定为0.40。不同年龄组的结果相似。结论ACQ是一种中等可靠、有效、反应灵敏的工具,具有足够的心理测量特性,可用于评估儿童近期哮喘控制情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
25.90
自引率
7.70%
发文量
1302
审稿时长
38 days
期刊介绍: The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.
期刊最新文献
Evaluating hypogammaglobulinemia after CD19 CAR T-cell therapy. Reply. Reply. Upper airway comorbidities of asthma in patients with aspirin-exacerbated respiratory disease. IRF2BP2 Deficiency: An important form of common variable immunodeficiency with inflammation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1